SINGAPORE (Mar 16): Cancer solution specialist Biolidics is raising $3.13 million from a share placement exercise mainly to expand the group’s businesses.

Under the terms of the share placement, the group will issue about 17.9 million new ordinary shares at 17.5 cents per share, which represents about 7.3% discount to its volume weighted average price of 18.9 cents per share as at the close of Mar 13.

Immediately after completion of the placement and assuming that no further shares are issued prior thereto, the group’s issued and paid-up share capital will increase to about 260.4 million shares, compared to 242.5 million shares currently.

The placement shares represent approximately 7.36% of the existing issued and paid-up share capital of the company and will represent approximately 6.86% of the enlarged share capital.

The group intends to use 51.5% or $1.6 million of the placement net proceeds to expand its presence in existing market, new market segments, and through establishing new sales channels; 25.6% or $0.8 million will be used to expansion of the group’s businesses through investments, M&A, JVs and/or collaborations with third parties; and about 23.0% or $0.7 million will be used for general working capital purposes.

As at 2.15pm, shares in Biolidics are trading 3.4% lower at 20 cents.

Biolidics issues 17.9 mil shares in placement exercise to raise $3.1 mil

'Transition credits' could sweeten deal for early retirement of coal-fired power plants: MAS, McKinsey paper

DPM Lawrence Wong appointed as GIC’s deputy chairman

Will the Rising Sun keep rising?

Fed signals higher-for-longer rates with hikes almost finished

EQT Impact Challenge offers platform for impact entrepreneurs to attain 'patient capital'

OUE resumes share buybacks; Wing Tai chairman's wife actively buying

Citi lowers Parkway Life REIT’s TP to $3.85 due to higher portfolio cap rate and higher discount rate

ISDN posts 11.3% lower revenue, 43.8% lower net profit for 1HFY2023

Double clicking on getting the most out of generative AI with Google Cloud

SAP to make business AI a norm 

Getting organised for AI

Twenty good fellows

Exit offer for Healthway Medical to go ahead after 50% acceptance

LHN Logistics to be delisted after 99.1% acceptance

Banks that downplay climate change face legal risks as liabilities hit capital planning

See the latest from Tom Ford Beauty, Ferragamo and more

Louis Vuitton announces a completely new strategy for the luxury brand’s watches

Patek Philippe’s Chronograph Collection blends timeless elegance with cutting-edge technology

Look out for policy shifts in Asia

M&A momentum in India set to grow

Keppel Corp seeks name change to 'Keppel' to reflect new structure

DBS keeps 'buy' call and 18 cents target price on Seatrium

Singapore banks tighten scrutiny of Chinese with other passports

Goh Jin Hian, former CEO of New Silkroutes Group and son of former PM Goh Chok Tong charged with false trading

Foodpanda deal could be ‘value-accretive’ for Grab, says HSBC

Biolidics issues 17.9 mil shares in placement exercise to raise $3.1 mil

Related News

Highlights

'Transition credits' could sweeten deal for early retirement of coal-fired power plants: MAS, McKinsey paper

Related News

MLT issues about 121.2 mil new units in private placement to raise $200 mil to pare debt

Quantum Healthcare to raise $1 million via placement of new shares

H2G Green to raise $1 mil by issuing 47.4 mil new shares to two investors